Epigene Labs

As VP of Translational Research, Camille is part of the Leadership team alongside the other VPs and the CEO, Akpéli. Together, they are responsible for turning the CEO’s vision into reality by defining strategy and overseeing the company’s operations. Camille also leads the Translational Research squad, which uses the company’s data and tools to conduct research programs that support the development of new treatments for cancer patients.

Prior to joining Epigene Labs, Camille started her career in academia working on innovative biotherapies for cardiovascular diseases. At Imperial College London, her doctoral research focused on developing novel biomaterial-based drug delivery systems for heart repair in collaboration with translational research labs at INSERM and University College London.

Pharmacist by training, Camille holds a Master's degree in Biomedical Engineering from Université de Paris / Paris Descartes, and a PhD degree in Bioengineering and Biomaterials from Imperial College London.

As VP of Computational Research, Kader plays a key role in aligning Epigene Labs' R&D strategy with the long-term vision of our CEO and Co-founder. He is responsible for designing our general and strategic roadmap, in collaboration with the Product and Translational Research teams.

Kader began his career in academic research, focusing on genetics, evolution, epidemiology and, more generally, mathematical modeling for biology. His thesis work focused on the detection and characterization of correlated evolutionary processes at the Collège de France and the Museum National d'Histoire Naturelle in Paris. He then carried out post-doctoral research at the University of Glasgow on modeling the dynamics and mechanics of epidemics in various environmental contexts.

He holds a master's degree in fundamental computer science from ENS Paris-Saclay, and a double master's degree in environmental science and policy from Sciences Po Paris and Université Pierre et Marie Curie. He obtained his PhD in genetics and bioinformatics in 2016 from Université Pierre et Marie Curie.

As a VP Product Data & Technology at Epigene Labs, Julien is prototyping and testing AI-powered tools for the aggregation and analysis of genomic data from multiple sources. He is also highly involved in setting up the company’s technology stack.

Prior to joining Epigene Labs, Julien was a data science consultant in the Ernst & Young Advisory Experience Lab. He has also been a teaching assistant for the Accenture Chair in Strategic Business Analytics at ESSEC Business School.

Julien holds a PharmD from Université Paris Descartes as well as master of science degree in data science from École CentraleSupélec and a master of science degree in management from ESSEC Business School (Grande École program).

Shashwat holds a Bachelor's in Technology from the Indian Institute of Technology & a Master's in Management from ESSEC Business School focussing on innovation & complexity management.

As Lead Product Manager, Shashwat is responsible for orchestrating the roadmap and product vision of Epigene Labs. He serves as the voice of Epigene Labs’ users, ensuring that their needs are well understood and addressed. Additionally, he is responsible for building processes and frameworks that bring state-of-the-art research directly to the users.

Shashwat has a background in deeptech product management specializing in building deeptech products from the ground up & scaling products in complex research-driven ecosystems including Adtech, and Humanoid Robotics amongst others.

Benjamin is a software engineer specializing in the design of advanced tools for the discovery of new therapeutic targets in oncology. As Lead Software Engineer, he is responsible for the development of the mCUBE platform, a scalable and secure ecosystem that offers tools through an intuitive interface, optimizing the utilization of biological data.

Before joining Epigene Labs, Benjamin began his career at Traaser, a CEA spin-off, where he contributed to the development of a biological sequence visualization platform aimed at facilitating the comparison of complex and varied omic data.

He holds a master’s degree in bioinformatics from Université Paris-Diderot and joined Epigene Labs in 2020, where he seeks to combine technical expertise with an understanding of biological challenges in the field of biotechnology.